CAR T-Cell therapy is a one-time treatment that uses a patient’s own immune cells to combat tough-to-treat cancers: lymphomas, some leukemias, and multiple myeloma. The first CAR T-Cell therapy (CAR T) became commercially available in 2017, and over the last...
At only a handful of clinical sites across the U.S., a one-time therapy is transforming cancer care. CAR T-Cell therapy, or just CAR T, uses genetically engineered versions of a patient’s own immune cells to seek and destroy tough-to-treat blood cancers, including...